{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:13Z","timestamp":1787068453706,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill &amp; Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1189065"],"award-info":[{"award-number":["OPP1189065"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["RG92770"],"award-info":[{"award-number":["RG92770"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vaccine.2024.05.031","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T07:21:48Z","timestamp":1716621708000},"page":"125983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modelling control strategies for pneumococcal meningitis outbreaks in the African meningitis belt"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-5080","authenticated-orcid":false,"given":"Liza","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-9340","authenticated-orcid":false,"given":"Heidi M.","family":"Soeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura V.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Latt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre A.","family":"Bita Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.031_b0005","unstructured":"Strategic Advisory Group of Experts on Immunization, SAGE meeting report, 5-7 October 2020., (2020). https:\/\/www.who.int\/news-room\/events\/detail\/2020\/10\/05\/default-calendar\/sage_meeting_october_2020."},{"key":"10.1016\/j.vaccine.2024.05.031_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2005-925523","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and clinical features","volume":"26","author":"Ortqvist","year":"2005","journal-title":"Semin. Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2024.05.031_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.05.031_b0020","unstructured":"World Health Organization, Defeating meningitis by 2030: baseline situation analysis., 2019."},{"key":"10.1016\/j.vaccine.2024.05.031_b0025","unstructured":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health, VIEW-hub, (2022). https:\/\/view-hub.org\/map\/."},{"key":"10.1016\/j.vaccine.2024.05.031_b0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/tmi.12860","article-title":"Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-Saharan Africa?","volume":"22","author":"Stuart","year":"2017","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2024.05.031_b0035","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1093\/infdis\/jiab105","article-title":"Pneumococcal meningitis outbreaks in Africa, 2000\u20132018: systematic literature review and meningitis surveillance database analyses","volume":"224","author":"Franklin","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0040","unstructured":"World Health Organization, Pneumococcal meningitis outbreaks in sub-Saharan Africa, Releve Epidemiol. Hebd. 91 (2016) 298\u2013302."},{"key":"10.1016\/j.vaccine.2024.05.031_b0045","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2017.12.069","article-title":"Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: analysis of outbreak data from Ghana","volume":"37","author":"Cooper","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.031_b0050","unstructured":"World Health Organization, Revised guidance on meningitis outbreak response in sub-Saharan Africa, Wkly. Epidemiol. Rec. Releve Epidemiol. Hebd. 89 (2014) 580\u2013586."},{"key":"10.1016\/j.vaccine.2024.05.031_b0055","unstructured":"World Health Organization, Managing meningitis epidemics in Africa: a quick reference guide for health authorities and health-care workers, Revised 2015, 2015. https:\/\/apps.who.int\/iris\/handle\/10665\/154595."},{"key":"10.1016\/j.vaccine.2024.05.031_b0060","unstructured":"WHO Regional Office for Africa, Standard operating procedures for surveillance of meningitis preparedness and response to epidemics in Africa, 2018. https:\/\/www.who.int\/publications-detail-redirect\/standard-operating-procedures-for-surveillance-of-meningitis-preparedness-and-response-to-epidemics-in-africa (accessed February 26, 2024)."},{"key":"10.1016\/j.vaccine.2024.05.031_b0065","unstructured":"World Health Organization, Pneumococcal vaccines: WHO position paper on their use in community outbreak settings., Wkly. Epidemiol. Rec. Releve Epidemiol. Hebd. 96 (2021) 105\u2013110."},{"key":"10.1016\/j.vaccine.2024.05.031_b0070","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob, Health"},{"key":"10.1016\/j.vaccine.2024.05.031_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12916-020-01601-1","article-title":"Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study","volume":"18","author":"Flasche","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2024.05.031_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-10-22","article-title":"African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults","volume":"10","author":"Gessner","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"2021","key":"10.1016\/j.vaccine.2024.05.031_b0085","first-page":"398","article-title":"Vaccine Impact Modelling Consortium, Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from to 2030: a modelling study","volume":"397","author":"Li","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2024.05.031_b0090","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2017.07.019","article-title":"Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: a mathematical model based on pre-vaccination data","volume":"35","author":"Ojal","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.031_b0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/inthealth\/ihu062","article-title":"Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria","volume":"6","author":"Ferrari","year":"2014","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2024.05.031_b0100","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.vaccine.2015.09.107","article-title":"Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac\u00ae","volume":"33","author":"Trotter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.031_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002495","article-title":"The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: a transmission dynamic modeling study","volume":"15","author":"Yaesoubi","year":"2018","journal-title":"PLOS Med"},{"key":"10.1016\/j.vaccine.2024.05.031_b0110","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2409.171058","article-title":"Outbreak of pneumococcal meningitis, paoua subprefecture, central african republic, 2016\u20132017","volume":"24","author":"Coldiron","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0115","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the african meningitis belt, 2004\u20132013","volume":"61","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2024.05.031_b0120","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1093\/infdis\/jiz308","article-title":"MenAfriNet consortium, MenAfriNet: a network supporting case-based meningitis surveillance and vaccine evaluation in the meningitis Belt of Africa","volume":"220","author":"Patel","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0125","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.vaccine.2020.06.002","article-title":"Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination","volume":"38","author":"Soeters","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.031_b0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12879-016-1914-3","article-title":"An outbreak of pneumococcal meningitis among older children (\u22655 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana","volume":"16","author":"Kwambana-Adams","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0135","unstructured":"United Nations Department of Economic and Social Affairs, Population Division, World Population Prospects 2022, Online Edition., (2022). https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/."},{"key":"10.1016\/j.vaccine.2024.05.031_b0140","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/infdis\/jiz301","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis, Burkina Faso, 2016\u20132017","volume":"220","author":"Soeters","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2024.05.031_b0145","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/jiz358","article-title":"Bacterial meningitis epidemiology in five countries in the meningitis belt of sub-Saharan Africa, 2015\u20132017","volume":"220","author":"Soeters","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0150","unstructured":"World Health Organization, Introduction of PCV (Pneumococcal conjugate vaccine)., (2022). https:\/\/immunizationdata.who.int\/pages\/vaccine-intro-by-antigen\/pneumo_conj.html."},{"key":"10.1016\/j.vaccine.2024.05.031_b0155","unstructured":"World Health Organization, Pneumococcal vaccination coverage., (2020). https:\/\/immunizationdata.who.int\/pages\/coverage\/pcv.html."},{"key":"10.1016\/j.vaccine.2024.05.031_b0160","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.031_b0165","first-page":"92","article-title":"A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)","volume":"5","author":"Patterson","year":"2016","journal-title":"TrialsVaccinol"},{"key":"10.1016\/j.vaccine.2024.05.031_b0170","first-page":"1826","article-title":"Pneumococcal polysaccharide vaccine efficacy","volume":"270","author":"Butler","year":"1993","journal-title":"An evaluation of current recommendations, JAMA"},{"key":"10.1016\/j.vaccine.2024.05.031_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166384","article-title":"Nationwide trends in bacterial meningitis before the introduction of 13-valent pneumococcal conjugate vaccine\u2014Burkina Faso, 2011\u20132013","volume":"11","author":"Kambir\u00e9","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.05.031_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/INF.0000000000000056","article-title":"13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or na\u00efve to 7-valent pneumococcal conjugate vaccine","volume":"33","author":"Frenck","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.05.031_b0185","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/infdis\/jiz355","article-title":"Meningococcal meningitis outbreaks in the african meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","volume":"220","author":"Fernandez","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.inhe.2009.12.009","article-title":"Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005\u20132006","volume":"2","author":"Alberti","year":"2010","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2024.05.031_b0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.vaccine.2021.01.017","article-title":"A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon","volume":"39","author":"Amani","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.031_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203205","article-title":"Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine","volume":"13","author":"Bozio","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.05.031_b0205","doi-asserted-by":"crossref","unstructured":"L.V. Cooper, J.M. Stuart, C. Okot, F. Asiedu-Bekoe, O.K. Afreh, K. Fernandez, O. Ronveaux, C.L. Trotter, Corrigendum to \u201cReactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana\u201d [Vaccine 37(37) (2019) 5657\u20135663], Vaccine 41 (2023) 7491\u20137492. Doi: 10.1016\/j.vaccine.2023.10.074.","DOI":"10.1016\/j.vaccine.2023.10.074"},{"key":"10.1016\/j.vaccine.2024.05.031_b0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/microorganisms10010127","article-title":"PCV13 vaccination of adults against pneumococcal disease: what we have learned from the community-acquired pneumonia immunization trial in adults (CAPiTA)","volume":"10","author":"Theilacker","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2024.05.031_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-8-53","article-title":"The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003\/2004","volume":"8","author":"Mooney","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.epidem.2015.01.001","article-title":"Pneumococcal vaccination in older adults in the era of childhood vaccination: public health insights from a Norwegian statistical prediction study","volume":"11","author":"Steens","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2024.05.031_b0225","first-page":"237","article-title":"Invasive pneumococcal disease among adults with hematological and solid organ malignancies: a population-based cohort study","volume":"106","author":"Garcia Garrido","year":"2021","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2024.05.031_b0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.031_b0240","unstructured":"M.D. Knoll, Conclusions from the PSERENADE Project: Implications for Pneumococcal Vaccine Policy and What is Happening Next [Oral Presentation]., in: 2021. https:\/\/www.meningitis.org\/getmedia\/0a2e175e-4e48-401e-8482-e2b2a9c5bf11\/Maria-Knoll?disposition=attachment."},{"key":"10.1016\/j.vaccine.2024.05.031_b0245","unstructured":"WHO Regional Office for Africa, Meningitis Weekly Bulletin: Week 10 2023., 2023. https:\/\/www.who.int\/publications\/m\/item\/meningitis-weekly-bulletin-6-to-12-march-2023."},{"key":"10.1016\/j.vaccine.2024.05.031_b0250","unstructured":"World Health Organization, Defeating meningitis by 2030: a global road map., 2021. https:\/\/www.who.int\/initiatives\/defeating-meningitis-by-2030."},{"key":"10.1016\/j.vaccine.2024.05.031_b0255","unstructured":"Strategic Advisory Group of Experts on Immunization, SAGE Working Group on Pneumococcal Vaccines (adjusted May 2023)., (2023). https:\/\/www.who.int\/groups\/strategic-advisory-group-of-experts-on-immunization\/working-groups\/pneumococcal-vaccines."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:09:15Z","timestamp":1778630955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":51,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0264410X24005905"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling control strategies for pneumococcal meningitis outbreaks in the African meningitis belt","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125983"}}